Venus Medtech (Hangzhou) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	158.34	298.04	774.4	1,879	2,955
Short-Term Investments	-	7.67	7.24	-	-
Trading Asset Securities	105.43	-	-	-	-
Cash & Short-Term Investments	263.77	305.7	781.64	1,879	2,955
Cash Growth	-13.72%	-60.89%	-58.41%	-36.40%	9.12%
Accounts Receivable	99.24	198.57	290.61	303.39	302.1
Other Receivables	-	55.04	58.27	80.75	53.8
Receivables	210.21	362.17	455.05	384.14	355.89
Inventory	96.75	98.06	112.94	104.4	90.52
Prepaid Expenses	-	-	0.28	1.07	1.02
Other Current Assets	96.28	36.54	258.17	99.93	36.98
Total Current Assets	667	802.48	1,608	2,469	3,440
Property, Plant & Equipment	116.24	522.11	693.47	461.28	250.75
Long-Term Investments	252.11	414.59	510	477.08	569.53
Goodwill	1,017	1,040	1,024	1,239	519.71
Other Intangible Assets	393.83	439.72	551.02	611.17	304.74
Long-Term Deferred Tax Assets	31.59	24.47	17.66	9.94	8.17
Other Long-Term Assets	42.18	6.76	9.15	15.86	16.93
Total Assets	2,519	3,250	4,414	5,283	5,109
Accounts Payable	15.95	30.23	33.86	9.13	8.75
Accrued Expenses	-	52.41	35.12	44.91	41.71
Short-Term Debt	5	17.52	136.83	100.12	0.5
Current Portion of Long-Term Debt	-	-	320.14	122.49	4.4
Current Portion of Leases	36.35	38.59	37.72	23.46	17.73
Current Income Taxes Payable	9.76	0.06	2.16	5.01	0.48
Current Unearned Revenue	2.49	3.21	29.54	4.32	17.84
Other Current Liabilities	171.05	219.74	209.79	182.68	117.13
Total Current Liabilities	240.6	361.75	805.17	492.1	208.53
Long-Term Debt	154.21	265.46	248.93	573.38	-
Long-Term Leases	20.78	47.53	82.56	80.2	48.15
Long-Term Unearned Revenue	-	-	1.63	0.6	-
Long-Term Deferred Tax Liabilities	-	-	17.78	17.41	53.45
Other Long-Term Liabilities	341.22	363.94	338.31	487.83	167.48
Total Liabilities	756.81	1,039	1,494	1,652	477.61
Common Stock	441.01	441.01	441.01	441.01	441.01
Additional Paid-In Capital	-	5,112	5,112	5,112	5,112
Retained Earnings	-	-3,596	-2,882	-2,178	-1,120
Treasury Stock	-	-72.55	-72.55	-72.55	-72.55
Comprehensive Income & Other	1,322	326.48	321.72	305.18	185.25
Total Common Equity	1,763	2,211	2,921	3,608	4,546
Minority Interest	-	-	-1.3	23.45	86.21
Shareholders' Equity	1,763	2,211	2,919	3,631	4,632
Total Liabilities & Equity	2,519	3,250	4,414	5,283	5,109
Total Debt	216.34	369.09	826.19	899.64	70.78
Net Cash (Debt)	47.43	-63.39	-44.55	979.79	2,884
Net Cash Growth	-	-	-	-66.03%	7.81%
Net Cash Per Share	0.11	-0.14	-0.10	2.24	6.58
Filing Date Shares Outstanding	437.9	437.9	437.9	437.9	437.9
Total Common Shares Outstanding	437.9	437.9	437.9	437.9	437.9
Working Capital	426.39	440.73	802.9	1,977	3,231
Book Value Per Share	4.03	5.05	6.67	8.24	10.38
Tangible Book Value	352.3	731.74	1,345	1,758	3,721
Tangible Book Value Per Share	0.80	1.67	3.07	4.01	8.50
Machinery	-	156.38	170.96	147.48	83.65
Construction In Progress	-	427.18	394.6	162.14	54.89
Leasehold Improvements	-	81.66	96.62	91.21	44.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.